Today Hologic (HOLX) Hits New Lifetime High

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Hologic ( HOLX) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Hologic as such a stock due to the following factors:

  • HOLX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $70.0 million.
  • HOLX has traded 12,376 shares today.
  • HOLX is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in HOLX with the Ticky from Trade-Ideas. See the FREE profile for HOLX NOW at Trade-Ideas

More details on HOLX:

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. HOLX has a PE ratio of 89. Currently there are 8 analysts that rate Hologic a buy, 1 analyst rates it a sell, and 7 rate it a hold.

The average volume for Hologic has been 1.6 million shares per day over the past 30 days. Hologic has a market cap of $10.2 billion and is part of the health care sector and health services industry. The stock has a beta of 1.13 and a short float of 4.9% with 5.67 days to cover. Shares are up 36% year-to-date as of the close of trading on Monday.

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Hologic Looks Good on the Charts

Five S&P 500 Boards Have No Women as Gender Balance Growth Stalls

Merck Up on Approval, Teva Sinks on Earnings and Asset Sales: Biotech Movers

Cramer: These Sectors Look Bullish (Part III)